These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 30818009)

  • 21. The effect of arginine glutamate on the stability of monoclonal antibodies in solution.
    Kheddo P; Tracka M; Armer J; Dearman RJ; Uddin S; van der Walle CF; Golovanov AP
    Int J Pharm; 2014 Oct; 473(1-2):126-33. PubMed ID: 24992318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advancing Therapeutic Protein Discovery and Development through Comprehensive Computational and Biophysical Characterization.
    Gentiluomo L; Svilenov HL; Augustijn D; El Bialy I; Greco ML; Kulakova A; Indrakumar S; Mahapatra S; Morales MM; Pohl C; Roche A; Tosstorff A; Curtis R; Derrick JP; Nørgaard A; Khan TA; Peters GHJ; Pluen A; Rinnan Å; Streicher WW; van der Walle CF; Uddin S; Winter G; Roessner D; Harris P; Frieß W
    Mol Pharm; 2020 Feb; 17(2):426-440. PubMed ID: 31790599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stability of buffer-free freeze-dried formulations: A feasibility study of a monoclonal antibody at high protein concentrations.
    Garidel P; Pevestorf B; Bahrenburg S
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):125-39. PubMed ID: 26455339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accelerated Aggregation Studies of Monoclonal Antibodies: Considerations for Storage Stability.
    Wälchli R; Vermeire PJ; Massant J; Arosio P
    J Pharm Sci; 2020 Jan; 109(1):595-602. PubMed ID: 31676272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-throughput screening and stability optimization of anti-streptavidin IgG1 and IgG2 formulations.
    Alekseychyk L; Su C; Becker GW; Treuheit MJ; Razinkov VI
    J Biomol Screen; 2014 Oct; 19(9):1290-301. PubMed ID: 25023322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a dual-wavelength size exclusion HPLC method with improved sensitivity to detect protein aggregates and its use to better characterize degradation pathways of an IgG1 monoclonal antibody.
    Bond MD; Panek ME; Zhang Z; Wang D; Mehndiratta P; Zhao H; Gunton K; Ni A; Nedved ML; Burman S; Volkin DB
    J Pharm Sci; 2010 Jun; 99(6):2582-97. PubMed ID: 20039394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mapping the Aggregation Kinetics of a Therapeutic Antibody Fragment.
    Chakroun N; Hilton D; Ahmad SS; Platt GW; Dalby PA
    Mol Pharm; 2016 Feb; 13(2):307-19. PubMed ID: 26692229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strategies to suppress aggregation of recombinant keratinocyte growth factor during liquid formulation development.
    Chen BL; Arakawa T; Hsu E; Narhi LO; Tressel TJ; Chien SL
    J Pharm Sci; 1994 Dec; 83(12):1657-61. PubMed ID: 7891291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of biophysical characterization techniques in predicting monoclonal antibody stability.
    Thiagarajan G; Semple A; James JK; Cheung JK; Shameem M
    MAbs; 2016; 8(6):1088-97. PubMed ID: 27210456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temperature-ramped studies on the aggregation, unfolding, and interaction of a therapeutic monoclonal antibody.
    Menzen T; Friess W
    J Pharm Sci; 2014 Feb; 103(2):445-55. PubMed ID: 24382634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The missing piece in the puzzle: Prediction of aggregation via the protein-protein interaction parameter A
    Koepf E; Schroeder R; Brezesinski G; Friess W
    Eur J Pharm Biopharm; 2018 Jul; 128():200-209. PubMed ID: 29723667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Submicron Aggregation of Chemically Denatured Monoclonal Antibody.
    Rowe JB; Flynn RP; Wooten HR; Noufer HA; Cancel RA; Zhang J; Subramony JA; Pechenov S; Wang Y
    Mol Pharm; 2018 Oct; 15(10):4710-4721. PubMed ID: 30142275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thermo-Optical Protein Characterization for Straightforward Preformulation Development.
    Wanner R; Breitsprecher D; Duhr S; Baaske P; Winter G
    J Pharm Sci; 2017 Oct; 106(10):2955-2958. PubMed ID: 28624419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. pH-shift stress on antibodies.
    Imamura H; Honda S
    Methods Enzymol; 2019; 622():329-345. PubMed ID: 31155060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Buffer, Protein Concentration and Sucrose Addition on the Aggregation and Particle Formation during Freezing and Thawing.
    Hauptmann A; Podgoršek K; Kuzman D; Srčič S; Hoelzl G; Loerting T
    Pharm Res; 2018 Mar; 35(5):101. PubMed ID: 29556730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a microflow digital imaging assay to characterize protein particulates during storage of a high concentration IgG1 monoclonal antibody formulation.
    Wuchner K; Büchler J; Spycher R; Dalmonte P; Volkin DB
    J Pharm Sci; 2010 Aug; 99(8):3343-61. PubMed ID: 20229596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonnative aggregation of an IgG1 antibody in acidic conditions: part 1. Unfolding, colloidal interactions, and formation of high-molecular-weight aggregates.
    Brummitt RK; Nesta DP; Chang L; Chase SF; Laue TM; Roberts CJ
    J Pharm Sci; 2011 Jun; 100(6):2087-103. PubMed ID: 21213308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Computational Design To Reduce Conformational Flexibility and Aggregation Rates of an Antibody Fab Fragment.
    Zhang C; Samad M; Yu H; Chakroun N; Hilton D; Dalby PA
    Mol Pharm; 2018 Aug; 15(8):3079-3092. PubMed ID: 29897777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surfaces Affect Screening Reliability in Formulation Development of Biologics.
    Zidar M; Posnjak G; Muševič I; Ravnik M; Kuzman D
    Pharm Res; 2020 Jan; 37(2):27. PubMed ID: 31907628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of a folding model and in situ spectroscopic techniques for rational formulation development and stability testing of monoclonal antibody therapeutics.
    Rao G; Iyer V; Kosloski MP; Pisal DS; Shin E; Middaugh CR; Balu-Iyer SV
    J Pharm Sci; 2010 Apr; 99(4):1697-706. PubMed ID: 19798762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.